Clicks Group Limited (CLCGY) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, Clicks Group Limited (CLCGY) es una empresa del sector Healthcare valorada en 0. Calificado con 46/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 15 mar 2026Clicks Group Limited (CLCGY) Resumen de Asistencia Médica y Tuberías
Clicks Group Limited is a South African health and beauty retailer and pharmaceutical distributor, operating through retail and distribution segments. With a network of approximately 840 stores and 620 in-store pharmacies, Clicks Group caters to the middle to upper-income markets, while UPD distributes pharmaceutical products to various healthcare providers.
Tesis de Inversión
Clicks Group Limited presents a compelling investment case due to its established market position in South Africa's health and beauty retail and pharmaceutical distribution sectors. The company's diversified revenue streams, stemming from both retail and wholesale operations, provide resilience against economic fluctuations. With a P/E ratio of 21.28 and a dividend yield of 3.05%, the company offers a blend of value and income. Key growth catalysts include expansion of its retail footprint and increasing demand for pharmaceutical products. Potential risks include regulatory changes in the healthcare sector and competition from other retailers and distributors. The company's beta of 0.23 suggests relatively low volatility compared to the broader market.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $4.04 billion, reflecting its significant presence in the South African market.
- P/E ratio of 21.28, indicating a reasonable valuation relative to its earnings.
- Profit margin of 6.3%, demonstrating its ability to generate profits from its operations.
- Gross margin of 25.4%, reflecting the efficiency of its supply chain and pricing strategies.
- Dividend yield of 3.05%, offering an attractive income stream for investors.
Competidores y Pares
Fortalezas
- Extensive retail network and distribution capabilities.
- Established brand reputation and customer loyalty.
- Diversified revenue streams from retail and distribution segments.
- Strong financial performance and profitability.
Debilidades
- Concentration of operations in South Africa.
- Exposure to regulatory changes in the healthcare sector.
- Dependence on key suppliers for pharmaceutical products.
- Potential for margin pressure from competition.
Catalizadores
- Ongoing: Expansion of retail footprint in South Africa, increasing market share.
- Ongoing: Growing demand for pharmaceutical products, boosting distribution revenue.
- Ongoing: Strategic partnerships to expand product offerings and market reach.
Riesgos
- Potential: Economic downturn in South Africa, impacting consumer spending.
- Potential: Changes in government regulations and healthcare policies.
- Potential: Increased competition from other retailers and distributors.
- Ongoing: Fluctuations in currency exchange rates, affecting ADR value.
Oportunidades de crecimiento
- Expansion of Retail Footprint: Clicks Group can continue to expand its retail footprint by opening new stores in underserved areas and increasing the number of in-store pharmacies. This expansion will allow the company to reach a wider customer base and increase its market share. The South African retail market is expected to grow at a rate of 5% annually, providing a favorable environment for expansion. Timeline: Ongoing.
- Increased Demand for Pharmaceutical Products: The demand for pharmaceutical products is expected to increase due to an aging population and rising healthcare awareness. Clicks Group, through its UPD distribution segment, is well-positioned to capitalize on this trend. The South African pharmaceutical market is projected to reach $10 billion by 2028. Timeline: Ongoing.
- Growth in Specialty Health and Wellness Products: Clicks Group can further expand its offerings in specialty health and wellness products, such as vitamins, mineral supplements, and sports nutrition. This will cater to the growing demand for preventative healthcare and wellness products. The global wellness market is estimated to be worth over $1.5 trillion. Timeline: Ongoing.
- E-commerce Expansion: Clicks Group can invest in its e-commerce platform to reach customers beyond its physical store network. This will allow the company to compete with online retailers and cater to the growing demand for online shopping. The South African e-commerce market is expected to grow at a rate of 15% annually. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Clicks Group can pursue strategic partnerships and acquisitions to expand its product offerings and market reach. This could include partnerships with other healthcare providers or acquisitions of smaller retail chains or pharmaceutical distributors. Timeline: Ongoing.
Oportunidades
- Expansion into new geographic markets.
- Growth in specialty health and wellness products.
- Increased demand for pharmaceutical products.
- E-commerce expansion and digital transformation.
Amenazas
- Economic downturn in South Africa.
- Increased competition from other retailers and distributors.
- Changes in government regulations and healthcare policies.
- Fluctuations in currency exchange rates.
Ventajas competitivas
- Extensive retail network of approximately 840 stores and 620 in-store pharmacies.
- Established brand reputation in the South African market.
- Integrated business model encompassing both retail and distribution.
- Strong relationships with pharmaceutical suppliers.
Acerca de CLCGY
Founded in 1968 and headquartered in Cape Town, South Africa, Clicks Group Limited has evolved into a prominent player in the health and beauty retail and pharmaceutical distribution sectors. Initially known as New Clicks Holdings Limited, the company rebranded as Clicks Group Limited in 2009. The company operates through two primary segments: Retail and Distribution. The Retail segment focuses on pharmacy, health, and beauty products, primarily targeting the middle to upper-income markets through its Clicks-branded stores. In addition to its core Clicks stores, the company also retails specialty health and wellness products under the General Nutrition Corporation (GNC) banner, luxury toiletries and cosmetics through The Body Shop, and fashion accessories via Claire's. The Distribution segment, operating under the UPD name, is involved in the wholesale and supply of pharmaceutical products to a diverse range of customers, including retail pharmacies, private hospitals, dispensing doctors, and retail health stores. Clicks Group's extensive network comprises approximately 840 stores and 620 in-store pharmacies across South Africa.
Qué hacen
- Operates as a health and beauty retailer in South Africa.
- Distributes pharmaceutical products to retail pharmacies, hospitals, and doctors.
- Retails pharmacy, health, and beauty products through Clicks stores.
- Sells specialty health and wellness products under the GNC brand.
- Offers luxury toiletries and cosmetics under The Body Shop brand.
- Provides fashionable jewelry and accessories through Claire's stores.
Modelo de Negocio
- Retails health, beauty, and pharmaceutical products directly to consumers through its store network.
- Distributes pharmaceutical products wholesale to healthcare providers.
- Generates revenue through product sales in both retail and distribution segments.
- Focuses on middle to upper-income markets in South Africa.
Contexto de la Industria
Clicks Group Limited operates within the healthcare sector, specifically in the medical pharmaceuticals and retail pharmacy industries. The South African retail pharmacy market is characterized by increasing demand for healthcare products and services, driven by an aging population and rising healthcare awareness. The competitive landscape includes other retail chains, independent pharmacies, and pharmaceutical distributors. Clicks Group's integrated business model, encompassing both retail and distribution, provides a competitive advantage in this market. The company's extensive store network and established brand reputation further solidify its position.
Clientes Clave
- Individual consumers seeking health, beauty, and pharmaceutical products.
- Retail pharmacies requiring pharmaceutical supplies.
- Private hospitals needing pharmaceutical products.
- Dispensing doctors requiring pharmaceutical supplies.
Finanzas
Gráfico e información
Precio de la acción de Clicks Group Limited (CLCGY): Price data unavailable
Últimas noticias
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CLCGY.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para CLCGY.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de CLCGY en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Bertina D. Engelbrecht B.Proc
CEO
Bertina Engelbrecht holds a B.Proc degree and has extensive experience in the retail and healthcare sectors. She has been with Clicks Group Limited for several years, holding various leadership positions before being appointed as CEO. Her background includes expertise in strategic planning, operations management, and business development. She has a proven track record of driving growth and improving operational efficiency.
Historial: Since becoming CEO, Bertina Engelbrecht has focused on expanding Clicks Group's retail footprint, enhancing its e-commerce capabilities, and strengthening its relationships with key suppliers. She has also overseen the implementation of several initiatives aimed at improving customer service and operational efficiency. Under her leadership, the company has maintained its strong financial performance and market position.
Información de ADR de Clicks Group Limited No patrocinado
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company that trades on U.S. stock exchanges. CLCGY is an ADR, meaning it allows U.S. investors to invest in Clicks Group Limited without directly dealing with foreign markets. Each CLCGY ADR represents a specific number of Clicks Group Limited's ordinary shares traded on its home market.
- Ticker del mercado local: Johannesburg Stock Exchange (JSE) in South Africa.
- Nivel de ADR: 1
- Ratio de ADR: 1:1
- Ticker del mercado local: CLCG
Información del mercado OTC de CLCGY
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited or no financial disclosure requirements and may not meet the listing standards of major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the lack of transparency and regulatory oversight compared to exchange-listed companies. This tier is also known for having the least liquidity.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure and transparency.
- Lower trading volume and liquidity.
- Wider bid-ask spreads.
- Potential for price volatility.
- Increased risk of fraud or manipulation.
- Verify the company's registration and legal status.
- Investigate the company's management team and their track record.
- Assess the availability and quality of financial information.
- Review the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal proceedings against the company.
- Established business operations in South Africa.
- Presence of a recognized brand (Clicks).
- Availability of some company information (though disclosure level is unknown).
- ADR structure allowing U.S. investment.
CLCGY Preguntas Frecuentes sobre Acciones de Healthcare
¿Cuáles son los factores clave para evaluar CLCGY?
Clicks Group Limited (CLCGY) actualmente tiene una puntuación IA de 46/100, indicando puntuación baja. Fortaleza clave: Extensive retail network and distribution capabilities.. Riesgo principal a monitorear: Potential: Economic downturn in South Africa, impacting consumer spending.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de CLCGY?
CLCGY actualmente puntúa 46/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de CLCGY?
Los precios de CLCGY se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre CLCGY?
La cobertura de analistas para CLCGY incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en CLCGY?
Las categorías de riesgo para CLCGY incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Economic downturn in South Africa, impacting consumer spending.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de CLCGY?
La relación P/E para CLCGY compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está CLCGY sobrevalorada o infravalorada?
Determinar si Clicks Group Limited (CLCGY) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de CLCGY?
Clicks Group Limited (CLCGY) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited analyst coverage due to OTC listing.
- Disclosure status on OTC market is unknown.